Document is current

Should Response-Adapted Therapy Now Be the Standard of Care for Advanced Hodgkin’s Lymphoma?

Crossref DOI link: https://doi.org/10.1007/s11864-017-0460-6

Published Online: 2017-03-13

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy